Paper20164017
Review of imaging solutions for integrated quantitative immunohistochemistry in the Pathology daily practice.
Rojo MG and 2 others. Folia Histochem Cytobiol, 2009. Cited by 94 papers, by iCite.
Cite this record
ConductScience Library. Review of imaging solutions for integrated quantitative immunohistochemistry in the Pathology daily practice. Papers, record 20164017. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20164017
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Review of imaging solutions for integrated quantitative immunohistochemistry in the Pathology daily practice.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Image Processing, Computer-Assisted | Major topic |
| Immunohistochemistry | Major topic |
| Neoplasms | Major topic |
| Pathology | Major topic |
| Humans | |
| In Situ Hybridization, Fluorescence | |
| Medical Informatics |
Source PubMed
Cited by54
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 94 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39579213 | Immunoexpression of placental growth factor (PlGF) and soluble FMS-like tyrosine kinase 1 (sFlt-1) in the placental bed of preeclamptic women of African ancestry living with HIV infection. | Histochem Cell Biol | 2024 | https://conductscience.org/library/papers/39579213 | PubMed |
| 39123488 | The Performance and Clinical Applicability of HER2 Digital Image Analysis in Breast Cancer: A Systematic Review. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39123488 | PubMed |
| 39045139 | Automated HER2 Scoring in Breast Cancer Images Using Deep Learning and Pyramid Sampling. | BME Front | 2024 | https://conductscience.org/library/papers/39045139 | PubMed |
| 37850170 | Label-Free Virtual HER2 Immunohistochemical Staining of Breast Tissue using Deep Learning. | BME Front | 2022 | https://conductscience.org/library/papers/37850170 | PubMed |
| 36830775 | Modification of Breast Cancer Milieu with Chemotherapy plus Dendritic Cell Vaccine: An Approach to Select Best Therapeutic Strategies. | Biomedicines | 2023 | https://conductscience.org/library/papers/36830775 | PubMed |
| 36544040 | Overview of the 2022 WHO Classification of Pituitary Adenomas/Pituitary Neuroendocrine Tumors: Clinical Practices, Controversies, and Perspectives. | Curr Med Sci | 2022 | https://conductscience.org/library/papers/36544040 | PubMed |
| 34532339 | Best Practices for Technical Reproducibility Assessment of Multiplex Immunofluorescence. | Front Mol Biosci | 2021 | https://conductscience.org/library/papers/34532339 | PubMed |
| 33297384 | A 'Real-Life' Experience on Automated Digital Image Analysis of FGFR2 Immunohistochemistry in Breast Cancer. | Diagnostics (Basel) | 2020 | https://conductscience.org/library/papers/33297384 | PubMed |
| 33072322 | Immune contexture analysis in immuno-oncology: applications and challenges of multiplex fluorescent immunohistochemistry. | Clin Transl Immunology | 2020 | https://conductscience.org/library/papers/33072322 | PubMed |
| 31173338 | The topology of vitronectin: A complementary feature for neuroblastoma risk classification based on computer-aided detection. | Int J Cancer | 2020 | https://conductscience.org/library/papers/31173338 | PubMed |
| 30818873 | Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer-Just About Ready for Prime-Time? | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/30818873 | PubMed |
| 30791580 | State-of-the-Art of Profiling Immune Contexture in the Era of Multiplexed Staining and Digital Analysis to Study Paraffin Tumor Tissues. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/30791580 | PubMed |
| 29849125 | Principles and approaches for reproducible scoring of tissue stains in research. | Lab Invest | 2018 | https://conductscience.org/library/papers/29849125 | PubMed |
| 29731981 | Programmed death-ligand 1 expression by digital image analysis advances thyroid cancer diagnosis among encapsulated follicular lesions. | Oncotarget | 2018 | https://conductscience.org/library/papers/29731981 | PubMed |
| 28859048 | Nanomechanical Characteristics of Cervical Cancer and Cervical Intraepithelial Neoplasia Revealed by Atomic Force Microscopy. | Med Sci Monit | 2017 | https://conductscience.org/library/papers/28859048 | PubMed |
| 28825136 | Breast cancer subtype discrimination using standardized 4-IHC and digital image analysis. | Virchows Arch | 2018 | https://conductscience.org/library/papers/28825136 | PubMed |
| 27920955 | PATMA: parser of archival tissue microarray. | PeerJ | 2016 | https://conductscience.org/library/papers/27920955 | PubMed |
| 27717363 | Content-based analysis of Ki-67 stained meningioma specimens for automatic hot-spot selection. | Diagn Pathol | 2016 | https://conductscience.org/library/papers/27717363 | PubMed |
| 27348626 | Automated measurement of estrogen receptor in breast cancer: a comparison of fluorescent and chromogenic methods of measurement. | Lab Invest | 2016 | https://conductscience.org/library/papers/27348626 | PubMed |
| 27312066 | Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms. | Mod Pathol | 2016 | https://conductscience.org/library/papers/27312066 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20164017
GET https://conductscience.org/api/papers/v1/20164017/cited_by?page=2